Not a good buy right now for an impatient entry: price is extended (RSI6 ~77.8) and sitting just below near-term resistance (R1 ~10.802), which raises near-term pullback risk.
No supportive Intellectia timing signal today (no AI Stock Picker / no SwingMax), so there’s no “must-buy now” trigger.
Options positioning is bullish (very low put/call ratios), but implied volatility is extremely elevated vs realized (IV 53% vs HV 18%), suggesting you may be paying up for risk at current levels.
Net: trend is bullish, Wall Street tone is improving, but the near-term setup is stretched—better viewed as a HOLD (not a fresh BUY at 10.78).
Technical Analysis
Trend: Bullish (SMA_5 > SMA_20 > SMA_200) and MACD histogram positive and expanding (0.0408), confirming upward momentum.
Momentum/Stretch: RSI_6 at 77.77 signals overbought/extended conditions; odds favor consolidation or a dip rather than clean continuation.
Levels: Pivot 10.525; immediate resistance R1 10.802 (price 10.78 is close), then R2 10.973. Support at S1 10.248.
Pattern-based forecast (similar candlesticks): indicates a weak near-term window (expected -6.43% next week), reinforcing “not a chase” here.
Sentiment: Very call-skewed positioning (OI put/call 0.19) and effectively no put volume today (volume put/call 0.0) = bullish trader bias.
Activity: Volume is elevated vs the 30-day average (~1202% of avg), suggesting heightened interest.
Volatility: IV_30d 53.24% vs historical vol 18.31% with IV percentile 84.46 = options are priced rich; great for sellers, but for a stock buyer it flags “expectation of movement” and potential event-risk pricing.
Interpretation: Options sentiment is bullish, but the high IV environment often coincides with late-stage/overheated moves or pre-event positioning.
Technical Summary
Sell
5
Buy
11
Positive Catalysts
can act as an attention catalyst if numbers confirm re-acceleration.
Neutral/Negative Catalysts
increases odds of a near-term pullback.
Financial Performance
Latest provided quarter: 2025/Q2.
Revenue: 2.627B, down -5.33% YoY (top-line contraction).
Net income: dropped to 0, down -100% YoY (profitability pressure in the period).
EPS: 0.09, up +200% YoY (improvement in per-share result despite net income data shown as 0—suggests mixed underlying drivers/adjustments).
Margin: Gross margin 64.51%, up +4.69% YoY (a clear positive—pricing/mix or cost improvements).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend is decisively positive (upgrades + higher price targets):
2026-01-23 Barclays: upgraded to Overweight, PT 420 GBp (from 380).
2026-01-21 HSBC: upgraded to Buy, PT 430 GBp.
2026-01-20 Jefferies: Buy, PT raised to 450 GBp.
2026-01-05 Goldman Sachs: added to European Conviction List (expects best-in-class sales growth).
2025-12-15 Morgan Stanley: Overweight, PT 420 GBp.
2025-11-07 Berenberg: Buy, PT 517 GBp.
Wall Street pros: strengthening conviction, expectation of improving sales growth, repeated target raises.
Wall Street cons: recent reported quarter shows revenue decline and weak net income, so the bull case depends on forward improvement rather than current-period strength.
Wall Street analysts forecast HLN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLN is 13.44 USD with a low forecast of 13.44 USD and a high forecast of 13.44 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast HLN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLN is 13.44 USD with a low forecast of 13.44 USD and a high forecast of 13.44 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 10.860
Low
13.44
Averages
13.44
High
13.44
Current: 10.860
Low
13.44
Averages
13.44
High
13.44
Barclays
Warren Ackerman
Equal Weight -> Overweight
upgrade
$380 -> $420
AI Analysis
2026-01-23
Reason
Barclays
Warren Ackerman
Price Target
$380 -> $420
AI Analysis
2026-01-23
upgrade
Equal Weight -> Overweight
Reason
Barclays analyst Warren Ackerman upgraded Haleon to Overweight from Equal Weight with a price target of 420 GBp, up from 380 GBp. The firm adjusted ratings in the European consumer staples group after introducing a new framework for the sector.
HSBC
Hold
to
Buy
upgrade
£430
2026-01-21
Reason
HSBC
Price Target
£430
2026-01-21
upgrade
Hold
to
Buy
Reason
HSBC upgraded Haleon to Buy from Hold with a 430 GBp price target.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HLN
